Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Fennec Pharmaceuticals Announces Commercial Launch Of PEDMARQSI In Germany, Which Is The First And Only Approved Therapy In The EU And U.K. For Prevention Of Ototoxicity, Or Hearing Loss, Induced By Cisplatin Chemotherapy

Author: Benzinga Newsdesk | February 07, 2025 07:10am

Posted In: FENC